LATAM LOWERS LDL-C

A phase 4 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 520 participants.

Also called NCT06501443

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 520 participants (planned count) (from the registry)
Sponsor
  • Novartis Registry lists this organization as the lead sponsor
Registry
  • NCT NCT06501443
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Argentina, Brazil (from the registry)
Registry status
  • Recruiting (from the registry)

Technical summary

Registry record NCT06501443. Randomized; no masking; primary purpose treatment. Start 2025-02-11 (actual); primary completion 2026-11-27 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
LATAM LOWERS LDL-C
Condition
Hypercholesterolaemia
Intervention (Drug)
Usual care
Intervention (Drug)
KJX839
Lead sponsor
Novartis Pharmaceuticals (class: industry)

Record details

Record id
cardio:ct-nct06501443
Content hash
2a413503db79cd7e63ac361457aae933f78c40c8a0508fa7584c3b3b1d2232dd